Aldebaran Therapeutics, Inc.

Biotechnology company · Waltham, Massachusetts, United States

Aldebaran Therapeutics, Inc. is a biotechnology company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $800,000 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Aldebaran Therapeutics at a glance

Typebiotechnology company

HeadquartersWaltham, Massachusetts, United States

Earliest incorporation on record2022

SEC CIK1918979

What does Aldebaran Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $800,000 sold (2022).

Frequently asked questions about Aldebaran Therapeutics

Where is Aldebaran Therapeutics headquartered?

Aldebaran Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.

What does Aldebaran Therapeutics do?

Aldebaran Therapeutics, Inc. is a biotechnology company.

When was Aldebaran Therapeutics founded?

The earliest incorporation on record for Aldebaran Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Repligen CorpWaltham, Massachusetts, United States
TScan Therapeutics, Inc.Waltham, Massachusetts, United States
La Jolla Pharmaceutical CoWaltham, Massachusetts, United States
MINERVA BIOTECHNOLOGIES CorpWaltham, Massachusetts, United States
Dianthus Therapeutics, Inc.Waltham, Massachusetts, United States
Viridian Therapeutics, Inc.Waltham, Massachusetts, United States
Pyramid Biosciences, Inc.Waltham, Massachusetts, United States
Mythic Therapeutics, Inc.Waltham, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences